ArticleInternational journal of molecular sciences2023

Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.